8N Similar outcome in a randomized phase III trial comparing docetaxel versus vinorelbine both combined with trastuzumab as first line treatment for metastatic or locally advanced human epidermal growth factor receptor 2 (HER2) positive breast cancer
M. Andersson, E. Lidbrink, E. Wist, K. Enevoldsen, A.B. Jensen, P.G. Sørensen, K. Bjerre, S. Møller, J. Bergh, S.T. LangkjerVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70035-5
File:
PDF, 43 KB
english, 2010